IL309923A - Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy - Google Patents
Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapyInfo
- Publication number
- IL309923A IL309923A IL309923A IL30992324A IL309923A IL 309923 A IL309923 A IL 309923A IL 309923 A IL309923 A IL 309923A IL 30992324 A IL30992324 A IL 30992324A IL 309923 A IL309923 A IL 309923A
- Authority
- IL
- Israel
- Prior art keywords
- nelonemdazk
- patients
- stroke
- ischemic stroke
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062988187P | 2020-03-11 | 2020-03-11 | |
| PCT/IB2021/000136 WO2021181159A1 (en) | 2020-03-11 | 2021-03-10 | Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL309923A true IL309923A (en) | 2024-03-01 |
Family
ID=77665492
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL309923A IL309923A (en) | 2020-03-11 | 2021-03-10 | Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy |
| IL296288A IL296288B2 (en) | 2020-03-11 | 2021-03-10 | Compositions and methods for treating reperfusion injury or bleeding after recanalization therapy |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL296288A IL296288B2 (en) | 2020-03-11 | 2021-03-10 | Compositions and methods for treating reperfusion injury or bleeding after recanalization therapy |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11826329B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4117648A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023517566A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230010187A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115515573A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021233206A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022018136A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3174709A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2022014343A2 (cg-RX-API-DMAC7.html) |
| IL (2) | IL309923A (cg-RX-API-DMAC7.html) |
| MX (2) | MX2022011214A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021181159A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12285182B2 (en) | 2018-10-10 | 2025-04-29 | Innova Vascular, Inc. | Devices and methods for removing an embolus |
| CN115515573A (zh) | 2020-03-11 | 2022-12-23 | Gnt制药有限公司 | 用于治疗再通疗法之后再灌注损伤或出血的组合物和方法 |
| CN113995723B (zh) | 2020-07-27 | 2025-02-18 | 浙江普洛家园药业有限公司 | 一种索法地尔冻干粉针剂的制备方法及其产品和用途 |
| JP2025500716A (ja) * | 2021-12-28 | 2025-01-14 | ジーエヌティー ファーマ カンパニー， リミテッド | 肺障害を処置するための組成物及び方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1551793B1 (en) * | 2002-06-19 | 2016-01-20 | AmKor Pharma, Inc. | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| KR100522188B1 (ko) * | 2003-01-20 | 2005-10-18 | 주식회사 뉴로테크 | 뉴로트로핀에 의해 유도되는 세포괴사 억제 방법 |
| WO2006126825A1 (en) | 2005-05-23 | 2006-11-30 | Choongwae Pharma Corporation | Composition comprising tetrafluorobenzyl derivatives or salts of thereof for injection |
| EP1883619B8 (en) * | 2005-05-25 | 2013-05-01 | JW Pharmaceutical Corporation | Process of preparation of substituted tetrafluorobenzylaniline compound and its pharmaceutically approved salts |
| KR101523345B1 (ko) * | 2008-04-28 | 2015-05-28 | 주식회사 지엔티파마 | 재관류 손상의 치료 또는 예방용 약학 조성물 |
| CN102617383A (zh) | 2012-03-20 | 2012-08-01 | 横店集团家园化工有限公司 | 索法地尔晶型、制备方法及包含索法地尔晶体的无菌粉末 |
| AU2016210973B2 (en) | 2015-01-27 | 2019-02-14 | Astrazeneca Ab | Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction |
| CN115515573A (zh) | 2020-03-11 | 2022-12-23 | Gnt制药有限公司 | 用于治疗再通疗法之后再灌注损伤或出血的组合物和方法 |
-
2021
- 2021-03-10 CN CN202180032761.3A patent/CN115515573A/zh active Pending
- 2021-03-10 WO PCT/IB2021/000136 patent/WO2021181159A1/en not_active Ceased
- 2021-03-10 AU AU2021233206A patent/AU2021233206A1/en active Pending
- 2021-03-10 MX MX2022011214A patent/MX2022011214A/es unknown
- 2021-03-10 US US17/197,736 patent/US11826329B2/en active Active
- 2021-03-10 IL IL309923A patent/IL309923A/en unknown
- 2021-03-10 KR KR1020227034966A patent/KR20230010187A/ko active Pending
- 2021-03-10 BR BR112022018136A patent/BR112022018136A2/pt unknown
- 2021-03-10 CA CA3174709A patent/CA3174709A1/en active Pending
- 2021-03-10 EP EP21768391.1A patent/EP4117648A4/en active Pending
- 2021-03-10 JP JP2022554288A patent/JP2023517566A/ja active Pending
- 2021-03-10 IL IL296288A patent/IL296288B2/en unknown
-
2022
- 2022-09-09 MX MX2025012439A patent/MX2025012439A/es unknown
- 2022-10-07 CO CONC2022/0014343A patent/CO2022014343A2/es unknown
-
2023
- 2023-08-21 US US18/235,986 patent/US12433861B2/en active Active
-
2025
- 2025-09-10 US US19/324,355 patent/US20260027076A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021181159A1 (en) | 2021-09-16 |
| CA3174709A1 (en) | 2021-09-16 |
| EP4117648A4 (en) | 2024-05-29 |
| BR112022018136A2 (pt) | 2022-10-25 |
| EP4117648A1 (en) | 2023-01-18 |
| IL296288B2 (en) | 2024-06-01 |
| KR20230010187A (ko) | 2023-01-18 |
| IL296288A (en) | 2022-11-01 |
| US11826329B2 (en) | 2023-11-28 |
| US20260027076A1 (en) | 2026-01-29 |
| CN115515573A (zh) | 2022-12-23 |
| IL296288B1 (en) | 2024-02-01 |
| US20230390231A1 (en) | 2023-12-07 |
| CO2022014343A2 (es) | 2023-02-16 |
| JP2023517566A (ja) | 2023-04-26 |
| AU2021233206A1 (en) | 2022-10-06 |
| MX2025012439A (es) | 2025-11-03 |
| MX2022011214A (es) | 2022-10-07 |
| US12433861B2 (en) | 2025-10-07 |
| US20210283080A1 (en) | 2021-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12433861B2 (en) | Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy | |
| KR101738201B1 (ko) | 구토방지제로서의 아미설프라이드의 용도 | |
| ES2623503T3 (es) | Composiciones para tratar náuseas y vómitos mediados centralmente | |
| EP3013335B1 (en) | Combination therapy for the treatment of cancer comprising eribulin and lenvatinib | |
| KR20120022721A (ko) | ＪＮＫ(ｃ-Ｊｕｎ 아미노 말단 키나제) 저해 펩티드를 이용한 망막 질환의 예방 또는 치료제, 망막 질환의 예방 또는 치료 방법, 및 이 펩티드의 용도 | |
| KR102266014B1 (ko) | 안질환 예방 또는 치료용 점안 조성물 | |
| CN117412751A (zh) | 用于预防或治疗肺纤维化的药物制剂 | |
| JP6051315B2 (ja) | 乾癬を処置するためのピドチモドの使用 | |
| BR122025026201A2 (pt) | Composições que compreendem o composto derivado de tetrafluorobenzila, frascos compreendendo as mesmas, uso terapêutico das mesmas e método para preparar o referido composto | |
| KR100869759B1 (ko) | 변비형 ｉｂｓ 예방제/치료제 | |
| CN104814933A (zh) | 栀子提取物冻干粉针剂及其制备方法 | |
| WO2022199551A1 (en) | Dc009 for treating acute ischemic stroke | |
| CN115956079B (zh) | 作为用于治疗新生儿缺氧缺血性脑损伤及相关疾病的药物的嘌呤衍生物 | |
| KR101768809B1 (ko) | 덱사메타손 및 글리벤클라마이드를 포함하는 뇌졸중의 예방 또는 치료용 약학적 조성물 | |
| WO2016047662A1 (ja) | 脳卒中の治療剤 | |
| KR20060123329A (ko) | 월경 곤란증의 예방 및/또는 치료제 | |
| JP2012136478A (ja) | 骨壊死予防及び／又は治療剤 | |
| KR20060120204A (ko) | 삼출성 중이염의 예방 및/또는 치료제 | |
| JPH0369324B2 (cg-RX-API-DMAC7.html) |